S&P 500   3,821.35
DOW   31,802.44
QQQ   299.94
S&P 500   3,821.35
DOW   31,802.44
QQQ   299.94
S&P 500   3,821.35
DOW   31,802.44
QQQ   299.94
S&P 500   3,821.35
DOW   31,802.44
QQQ   299.94
Log in

CytRx Short Interest Ratio and Short Volume

+0.12 (+3.46 %)
(As of 03/8/2021 12:00 AM ET)
Today's Range
Now: $3.59
50-Day Range
MA: $2.80
52-Week Range
Now: $3.59
Volume78,204 shs
Average Volume178,105 shs
Market Capitalization$130.96 million
P/E RatioN/A
Dividend YieldN/A

Short Interest

CytRx (OTCMKTS:CYTR) Short Interest Data

Current Short Volume42,400 shares
Previous Short Volume46,900 shares
Change Vs. Previous Month:-9.59%
Dollar Volume Sold Short$105,152.00
Short Interest Ratio / Days to Cover0.2
Last Record DateFebruary, 12 2021
Outstanding Shares36,480,000 shares
Percentage of Shares Shorted0.12%
Today's Trading Volume78,204 shares
Average Trading Volume178,105 shares
Today's Volume Vs. Average-56.09%

Short Interest Over Time

CytRx (OTCMKTS:CYTR) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/12/202142,400 shares $105,152.00 -9.6%N/A0.2 $2.48
1/29/202146,900 shares $100,835.00 -3.1%N/A0.2 $2.15
1/15/202167,700 shares $163,834.00 +35.1%N/A0.2 $2.42
12/31/202067,700 shares $125,245.00 +35.1%N/A0.2 $1.85
12/15/202067,700 shares $79,209.00 +35.1%N/A0.2 $1.17
11/30/202050,100 shares $47,595.00 +30.5%N/A0.4 $0.95
11/15/202038,400 shares $27,264.00 +1.9%N/A0.8 $0.71
10/30/202037,700 shares $21,866.00 -1.3%N/A0.5 $0.58
10/15/202038,200 shares $23,684.00 +0.5%N/A0.6 $0.62
9/30/202038,000 shares $22,800.00 -13.0%N/A0.8 $0.60
9/15/202043,700 shares $27,531.00 +1.4%N/A0.7 $0.63
8/31/202043,100 shares $25,010.93 +14.3%N/A0.2 $0.58
8/14/202037,700 shares $25,730.25 -1.6%N/A0.8 $0.68
7/31/202038,300 shares $25,278.00 -41.5%N/A0.4 $0.66
7/15/202065,500 shares $43,230.00 +20.6%N/A1.1 $0.66
6/30/202054,300 shares $37,195.50 -19.2%N/A0.6 $0.69
6/15/202067,200 shares $46,368.00 -41.4%N/A0.3 $0.69
5/29/2020114,600 shares $83,658.00 +94.6%N/A0.4 $0.73
5/15/202058,900 shares $41,819.00 +27.8%N/A0.6 $0.71
4/30/202046,100 shares $33,192.00 No ChangeN/A1.1 $0.72
4/15/202046,100 shares $19,408.10 -10.3%N/A1.1 $0.42
3/31/202051,400 shares $21,588.00 -17.2%N/A0.4 $0.42
3/13/202062,100 shares $24,219.00 +62.1%N/A0.4 $0.39
2/28/202038,300 shares $11,873.00 -37.9%N/A0.1 $0.31
2/14/202061,700 shares $29,616.00 +33.0%N/A0.3 $0.48

CytRx (OTCMKTS:CYTR) Short Interest FAQ

speech bubbles
speech bubbles

What is CytRx's current short interest?

Short interest is the volume of CytRx shares that have been sold short but have not yet been closed out or covered. As of February 12th, investors have sold 42,400 shares of CYTR short.

Is CytRx's short interest increasing or decreasing?

CytRx saw a decrease in short interest in the month of February. As of February 12th, there was short interest totaling 42,400 shares, a decrease of 9.6% from the previous total of 46,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does CytRx's short interest compare to its competitors?

0.00% of CytRx's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to CytRx: Gritstone Oncology, Inc. (8.43%), Fusion Pharmaceuticals Inc. (1.62%), Harpoon Therapeutics, Inc. (2.94%), AVROBIO, Inc. (0.00%), Freeline Therapeutics Holdings plc (0.09%), Opthea Limited (0.00%), Innate Pharma S.A. (0.00%), Innate Pharma S.A. (0.00%), Codiak BioSciences, Inc. (3.24%), and Cardiff Oncology, Inc. (18.60%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: ViacomCBS Inc. ($6.50 billion), Aon Plc ($5.58 billion), Charter Communications, Inc. ($5.30 billion), Analog Devices, Inc. ($4.97 billion), Snap Inc. ($3.80 billion), Futu Holdings Limited ($2.84 billion), Airbnb, Inc. ($2.40 billion), Discovery, Inc. ($2.35 billion), Snowflake Inc. ($2.07 billion), and The Kroger Co. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short CytRx stock?

Short selling CYTR is an investing strategy that aims to generate trading profit from CytRx as its price is falling. CytRx's stock is trading up $0.12 today. To short CytRx stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that CytRx will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against CytRx?

A short squeeze for CytRx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CYTR, which in turn drives the price of the stock up even further.

How often is CytRx's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CYTR, twice per month. The most recent reporting period available is February, 12 2021.

This page was last updated on 3/9/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.